NCT05524012View on ClinicalTrials.gov

Longitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2022

Primary Completion Date

January 31, 2026

Study Completion Date

September 30, 2030

Conditions
Locally Advanced Rectal CarcinomaNeoadjuvant TreatmentRadiotherapyAdaptive Treatment
Interventions
DIAGNOSTIC_TEST

Blood sample

longitudinal blood samples for CTC monitoring

DEVICE

MRI scan

longitudinal MRI scans (non-contrast enhanced)

Trial Locations (1)

Unknown

Department of Radiotherapy and Radiation Oncology, Jena University Hospital, Jena

All Listed Sponsors
lead

Jena University Hospital

OTHER